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The melanocortin receptors, MC3R and MC4R, are G
protein-coupled receptors that are involved in regulat-
ing energy homeostasis. Using a luciferase reporter
gene under the transcriptional control of a cAMP-
responsive element (CRE), the coupling efficiency of the
MC4R and MC3R to G-proteins was previously shown to
be different. MC4R exhibited only 30–50% of the maxi-
mum activity induced by MC3R. To assess the role of the
different MC3R and MC4R domains in G-protein cou-
pling, several chimeric MC3R/MC4R receptors were con-
structed. The relative luciferase activities, which were
assessed after transfecting the chimeric receptors into
HEK 293T cells, showed that the i3 (3rd intracellular)
loop domain has an essential role in the differential
signaling of MC3R and MC4R. To reveal which amino
acid residue was involved in the MC4R-specific signal-
ing in the i3 loop, a series of mutant MC4Rs was con-
structed. Reporter gene analysis showed that single mu-
tations of Arg220 to Ala and Thr232 to either Val or Ala
increased the relative luciferase activities, which sug-
gests that these specific amino acids, Arg220 and Thr232,
in the i3 loop of MC4R play crucial roles in G-protein
coupling and the subtype-specific signaling pathways.
An examination of the inositol phosphate (IP) levels in
the cells transfected with either MC3R or MC4R after
being exposed to the melanocortin peptides revealed
significant stimulation of IP production by MC3R but no
detectable increase in IP production was observed by
MC4R. Furthermore, none of the MC4R mutants dis-
played melanocortin peptide-stimulated IP production.
Overall, this study demonstrated that MC3R and MC4R
have distinct signaling in either the cAMP- or the inosi-
tol phospholipid-mediated pathway with different con-
formational requirements.
Melanocortins are peptide hormones that are derived from
the precursor peptide pro-opiomelanocortin, by a series of pro-
teolytic cleavages (1). The melanocortins are known to have a
broad spectrum of physiological actions, which include the reg-
ulation of melanocyte pigmentation (2), thermoregulation (3),
obesity (4), control of the cardiovascular system (5), and learn-
ing and memory (6), and have also been found to have immu-
nomodulatory effects (7). These hormones mediate their effects
through G protein-coupled receptors by stimulating adenylate
cyclase (8). To date five melanocortin receptor subtypes, with
different patterns of tissue expression in the brain and periph-
eral body, have been cloned and characterized (8–12).
It has been reported that the activation of melanocortin
4 receptor (MC4R)1 by -melanocyte-stimulating hormone
(MSH) increases energy expenditure and decreases food intake.
Moreover, the genetic disruption of MC4R was found to cause
obesity in mice (13). Recent experiments in MC3R-null mice
indicate that the inactivation of MC3R results in increased fat
mass and reduced body mass, despite the fact that the animals
were hypophagic and maintained normal metabolic rates (14,
15). These results suggest the nonredundancy of the MC3R and
MC4R melanocortin receptors in the regulation of energy
homeostasis (14, 15).
In previous studies, we and others have demonstrated that
heterologously expressed MC3R and MC4R are coupled to the
cAMP pathway. We analyzed several -MSH analogues upon
stimulation of MC3R and MC4R using a CRE (cAMP respon-
sive element)-mediated reporter gene transcription activity as-
say (16), and were able to show that both MC3R and MC4R,
expressed in human cell line HEK 293T, stimulate transcrip-
tion when stimulated using different analogues of melanocortin
at different levels. Our previous studies have shown that
MC3R and MC4R may have differential efficiencies and/or
modes of signaling in terms of G-protein coupling, in addition to
their specific ligand-receptor interactions, which can specify
subtype-specific signaling pathways in vivo (16).
The role of the third intracellular (i3) loop in G-protein
coupling specificity has been investigated extensively for many
seven-transmembrane domain receptors, including adrenergic,
serotonergic, muscarinic, and dopaminergic receptors (17–21).
For example, swapping experiments performed upon two dif-
ferent G protein-coupled receptors demonstrated the impor-
tance of this loop in selective coupling to specific G-protein/
effector systems (22, 23).
To identify the role(s) of the third intracellular loop of the
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MC3R and MC4R receptors in terms of G-protein coupling
specificity and receptor activation, several chimeras were con-
structed and characterized. We used the CRE-luciferase re-
porter gene assay to score the efficacy of receptor-G proteins
coupling (24, 25). In parallel, amino acid mutations were gen-
erated in the third intracytoplasmic loop of MC4R to identify
the residues that play a role in G-protein coupling. These
mutant receptors were examined in terms of their abilities to
bind melanocortin receptor-specific ligands and with respect to
signal transduction at the cAMP level.
EXPERIMENTAL PROCEDURES
Construction of Chimeric Receptors—Chimeric receptors were made
by using the polymerase chain reaction with sequence substitution of
the i3 and carboxyl-terminal domain in rat MC3R (GenBankTM acces-
sion number X70667) and human MC4R (GenBankTM accession num-
ber S77415). Overlapping primers were designed from the junction of i3
and the carboxyl-terminal in MC3R and MC4R (Table I). To construct
the chimeras, fragments originating from each receptor were first am-
plified in separate reactions with the indicated primers, namely, a
vector primer and an overlapping primer directed against the desired
junction sites between MC3 and MC4R receptors. Fragments were
isolated and purified from agarose gel and used as templates in a
second polymerase chain reaction performed with two outer vector
primers. For example, to construct chimera 1, the MC3R sequence
from the amino terminus to the carboxyl-terminal end of transmem-
brane domain V was amplified using a vector primer (MC3R-F, Table
I) and an overlapping 36-mer primer (MC3R-R, Table I). This over-
lapping primer contained 24 bases (in bold, Table I) from the tem-
plate sequence (MC3R) and an additional 12 bases from MC4R (in
italics, Table I). In the same way, a second PCR was performed using
two primers (MC4R-F and MC4R-R) with an MC4R template. These
PCR products were purified and used as templates for another PCR,
which was performed using the MC3R-F and MC4R-R primers. Final
PCR products of each chimera were isolated and purified from agar-
ose gel. All chimeric inserts were subsequently subcloned into pSV
(16, 25) using the BamHI and XhoI enzyme restriction sites. All
chimeric inserts were sequenced on an automatic sequencer, ALF-
express (Amersham Biosciences), using a dideoxy terminator cycle
sequencing kit (Amersham Biosciences). No point mutations were
observed, and exact substitutions of all domains were found.
Construction of MC4R Mutant Receptors—The MC4R and MC3R
sequences were extracted from the NCBI data base and aligned using
the ClustalW and GENE DOC programs. Primers were designed from
the sequences in the I3 loop domain of MC4R using a recommended
protocol (QuikChangeTM Site-directed mutagenesis Kit, Stratagene)
(Table II). Briefly, denatured double stranded plasmid DNA was an-
nealed to a mutagenic primer pair of forward and reverse oligonucleo-
tides and the new strand of DNA so obtained was synthesized with pfu
DNA polymerase (Pfu Turbo DNA polymerase, Stratagene) by polym-
erase chain reaction (95 °C for 30 s, 55 °C for 1 min, and 68 °C for 12
min for 16 cycles). Methylated template DNA was digested with DpnI
enzyme for 1 h at 37 °C. Reaction mixtures were then used to transform
competent XL-1 blue Escherichia coli and the plasmid DNA was pre-
pared. Inserts of plasmid DNAs were sequenced entirely and all amino
acid changes were confirmed by full double stranded sequencing.
Expression of Melanocortin Receptors and Luciferase Reporter Gene
Assay—Rat MC3R and human MC4R cDNA, kindly provided by
Dr. Roger D. Cone, were cloned into pSV expression vector (16, 25). For
receptor expression, HEK 293T cells were grown in Dulbecco’s modified
Eagle’s medium with 10% fetal bovine serum and transfected with
pSV-rMC3R and pSV-hMC4R, respectively, using FuGENE 6 transfec-
tion reagent (Roche Molecular Biochemicals) using the procedure rec-
ommended by the manufacturer. Briefly, 5–7  105 cells were plated
per six-well culture dish and transfected with 1 g of pCRE-luc (Strat-
agene), 0.5 g of plasmid pCH11O carrying the -galactosidase gene,
and 1 g of each chimeric receptor or MC4R mutant plasmid DNA.
After 6 h, the transfection mixture was replaced with fresh growth
medium. Twenty-four hours after transfection, HEK 293T cells were
treated for 3 h with various concentrations of -MSH-ND or NDP-MSH
in Dulbecco’s modified Eagle’s medium supplemented with 0.5% bovine
serum albumin. After treatment, the cells were lysed and assayed for
luciferase activity using the luciferase assay system (Promega), and
luminescence was measured using a 96-well luminometer (Microlumat;
TABLE I
Sequences of overlapping primer for chimeric receptor construction
Overlapping primers were designed from the junction of the third
intracellular loop domain and the carboxyl terminus in each rat MC3R
and human MC4R. Nucleotide sequences from MC3R are shown in bold
font and sequences from MC4R are shown in italics.
TABLE II
Oligonucleotide primers for MC4R mutant receptor construction
MC4R mutants were constructed by site-directed mutagenesis with
the indicated primers. The nucleotides of mutant amino acid residues
are shown in bold italics.
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EG & G Berthold, Bad Wilbad, Germany). The expression of the re-
porter gene was normalized (26) using -galactosidase activity (27).
Transfection in the control group was performed under the transfection
conditions described above with 1 g of pCRE-luc, 0.5 g of plasmid
pCH110 carrying the -galactosidase gene, and 1 g of chimeric recep-
tor or MC4R mutant plasmid DNA, but without stimulating by the
melanocortin peptides. Results are expressed as the ratio of luciferase
activity of the transfected cells to that of the unstimulated controls. The
mean values of the data obtained were fitted to a sigmoid curve with a
variable slope factor using nonlinear squares regression in GraphPad
Prism software. EC50 values (nM) are described as mean  S.E.
Ligand Binding Study—Iodinated NDP-MSH, 125I(iodotyrosyl-2)-
[Nle4,D-Phe7]-MSH, was prepared using the chloramine-T method, as
follows. 1 mCi (10 l) of Na125I (PerkinElmer Life Sciences) was added
to 5 g of NDP-MSH in 100 l of 200 mM sodium phosphate buffer (pH
7.2), and 20 l of 2.8 mg/ml chloramine T solution in 200 mM sodium
phosphate (pH 7.2) was then added for 15 s, at which time the reaction
was stopped with 50 ml of 3.6 mg/ml sodium metabisulfate. The reac-
tion mixture was then diluted in 1 ml of 0.1% bovine serum albumin
solution containing 0.1% trifluoroacetic acid and purified using a Sep-
Pak C18 cartridge (Waters) and Sephadex G-25 gel filtration chroma-
tography. A 100-l aliquot of a 0.1% solution of bovine serum albumin
was added to all radioactive fractions. Specific activity of the [125I]NDP-
MSH was measured, which was 0.59 pmol/100,000 cpm. For the
binding assay, 24 h after transfection in HEK 293T cells, medium was
removed and the cells were washed twice with washing buffer (50 mM
Tris, 100 mM NaCl, 5 mM KCl, 2 mM CaCl2, pH 7.2). The cells were then
immediately incubated in wells at 37 °C for 2 h with 0.25 ml of binding
buffer (containing 50 mM Tris, 100 mM NaCl, 5 mM KCl, 2 mM CaCl2, 5%
Hanks’ balanced salt solution, and 0.5% bovine serum albumin, at pH
7.2) containing a constant concentration of [125I]NDP-MSH and appro-
priate concentrations of the competing unlabeled ligand in each well. At
the end of the incubation, the plates were placed on ice for 15 min and
the cells were washed twice with 0.5 ml of ice-cold binding buffer. Cells
were detached from the plates using 0.5 ml of 0.5 N NaOH twice.
Radioactivity was measured (Workman automatic -counter) and Kd
and Bmax values were calculated, to a 95% confidence interval, using
GraphPad Prism software.
Determination of Total Inositol Phosphate—HEK 293T cells were
plated at a density of 3  105 cells/well in six-well plates and allowed to
recover for 24 h. The cells were then transfected with pSV-rMC3R and
pSV-hMC4R, respectively, using the FuGENE 6 transfection reagent
(Roche Molecular Biochemicals) as described above, after which 2 ml of
Dulbecco’s modified Eagle’s medium supplemented with 20% fetal bo-
vine serum was added to each well and the cells were incubated for an
additional 24 h. The medium was then aspirated, and cells were incu-
bated for 16 h in myo-inositol-free Dulbecco’s modified Eagle’s medium
supplemented with myo-[3H]inositol (1 Ci/ml, 25 mCi/mmol) (DuPont
Biotechnology Systems). The cells were then pretreated with Dulbecco’s
modified Eagle’s medium supplemented with 20 mM LiCl for 30 min,
and then incubated in the absence or presence of different concentra-
tions of -MSH for 5 s to 3 or 45 min. The reaction was stopped by the
addition of perchloric acid to a final concentration of 5% (w/v). Cells
were extracted and [3H]inositol polyphosphates were analyzed by
anion-exchange high performance liquid chromatography, using a Par-
tisphere SAX column (Whatman), as described previously (28, 29). All
experiments were performed in triplicate.
Statistical Analysis—Cellular responses to the various peptides were
compared using one-way analysis of variance and the Student’s t test
with Instat software (GraphPad).
RESULTS
MC3R and MC4R share 60% overall amino acid identity and
76% similarity. The transmembrane regions show the highest
degree of homology, whereas the intra- and extracellular loops
show the lowest. As depicted in Fig. 1, four types of MC3R/
MC4R chimeric receptors were constructed to investigate the
role of the different domains of MC3R and MC4R in G-protein
coupling. These chimeric receptors were designed to determine
the contribution made by the i3 domain to G-protein coupling
efficiency. Thus, the i3 loop and the remainder of the COOH-
terminal domain of MC3R were swapped with the correspond-
ing domain of the MC4R (named chimera 1), and in chimera 2,
only the i3 loop of MC3R was swapped with that of MC4R. In
chimera 3, the i3 loop and the cytoplasmic COOH-terminal loop
of MC3R were swapped with that of MC4R, and in chimera 4,
only the cytoplasmic loop of MC3R (named chimera 3 or 4,
respectively) was swapped with the corresponding region of the
MC4R.
Binding and CRE-mediated Reporter Gene Activity of Chi-
meric Receptors—Wild type MC3R, MC4R, and the chimeric
MC3/MC4R receptors were transiently transfected into HEK
293T cells. MC3R, MC4R, and all chimeric receptors all bound
[125I]NDP-MSH with high affinity, as shown in Table III. The
affinities of the expressed MC3R and MC4R receptors for
[125I]NDP-MSH were 3.775  0.4906 and 4.269  1.0090 nM,
respectively, and the Bmax values estimated for the two recep-
tors were very similar (361.7  20.47 and 375.9  40.07
fmol/mg of protein for MC3R and MC4R, respectively, Table
III). The respective chimeric receptors were found to have
affinities that were similar to those of the parent receptors.
These data indicate that substitution of the third intracellular
loop had no significant conformational influence on ligand-
binding domains, which are localized mainly within the trans-
membrane domain regions.
In parallel, wild type and chimeric MC3/MC4R receptors
were transfected with the CRE-luciferase reporter gene into
HEK 293T cells, as described earlier (16). In our previous study
(16), using a luciferase reporter plasmid containing a CRE in
its promoter (pCRE-Luc), we were able to show that it is pos-
FIG. 1. Schematic representation of MC3/MC4R chimeric re-
ceptors. Bold lines denote the sequence of MC3R and dotted lines the
sequence of MC4R. Black rectangles represent putative transmembrane
domains.
TABLE III
125I-Labeled NDP-MSH binding to MC3R and MC4R,
and to chimeric receptors
Kd and Bmax values were calculated at a 95% confidence interval
using GraphPad Prism software for binding assay using 125I-labeled
NDP-MSH upon MC3R and MC4R, and upon the chimeric receptors
expressed in HEK 293T cells. Values are mean  S.E. from at least
three independent experiments.
Bmax Kd
fmol/mg protein nM
MC3R 361.7  20.47 3.775  0.4906
MC4R 375.9  40.07 4.269  1.0090
Chimera 1 329.2  21.56 3.310  0.5175
Chimera 2 329.3  18.82 3.558  0.4753
Chimera 3 298.7  23.34 3.164  0.5977
Chimera 4 381.2  53.52 4.298  1.3350
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sible to monitor variations in intracellular cAMP levels induced
by transient transfections of MC3 and MC4 receptors. When
increasing concentrations of -MSH analogues were added, a
typical dose-dependent and saturable induction of luciferase
activity was observed (Fig. 2). However, we detected no signif-
icant effect of the -MSH analogues on cells transfected with
the reporter plasmid alone, which rules out the possibility of
the presence of endogenous melanocortin receptors in the cell
lines used for transfection, as the presence of such endogenous
species might have affected the measured luciferase activity
levels (data not shown). Another control transfection, using a
luciferase reporter vector devoid of a CRE sequence, showed no
significant response, demonstrating that the luciferase activity
measured was dependent of the presence of the CRE site in the
reporter plasmid (data not shown). These experiments demon-
strate that the measured CRE-luciferase activity levels reflect
the effects elicited by the receptors on changes in the intracel-
lular cAMP levels, as represented by changes in cAMP-medi-
ated gene expression, and thus provided evidence of receptor-G
protein-effector interaction. Alterations in the abilities of dif-
ferent chimeric receptors to induce luciferase reporter gene
activity were measured.
As described previously the luciferase activity induced by
MC4R was found to be about 30–50% of the level induced by
MC3R. Interestingly, chimera 1, where the i3 loop with the rest
of the COOH-terminal domain of the MC3R were swapped with
the corresponding domain of the MC4R, was similar to native
MC3R in terms of its maximal reporter gene activity. Chimera
4 showed a slight increase in maximal reporter gene activity.
However, the abilities of chimeras 2 and 3 to induce luciferase
reporter gene activity were significantly affected, and de-
creased by 60 and 45% in maximal reporter gene activity,
respectively (Fig. 2, A and B). The EC50 calculated from the
dose-response curves was in general highly reproducible over
several experiments, results are summarized in Table IV. The
ability to induce the luciferase reporter gene activity of chimera
2 receptors upon stimulation with -MSH-ND was significantly
affected by 8.7-fold (EC50 11.37 nM) versus MC3R (EC50 1.3
nM), whereas the EC50 values of other chimeric receptors were
not significantly changed (Table IV). Therefore, our analysis of
the four chimeras suggests that the dominant loss of G-protein
coupling efficiency was associated mainly with the 3rd intra-
cytoplasmic loop of the MC3R and MC4R receptors.
Binding and CRE-mediated Reporter Gene Transcription
Activity of Mutant MC4R—To assess the role of the i3 loop and
to establish whether mutations in the i3 loop of MC4R alter the
coupling profiles of the receptor, amino acid mutations were
generated in the i3 loop of MC4R (Fig. 3). Charged amino acids,
such as, arginine 220, lysine 224, arginine 225, and arginine
236 were substituted with alanine (R220A, K224A, R225A, and
R236A respectively), which lacks an amino acid chain beyond
the  carbon and also avoids the introduction of steric hin-
drance or unwanted ionic interactions. We also substituted
threonine 232 with valine (T232V), a nonpolar amino acid, or
FIG. 2. Relative cAMP-mediated lu-
ciferase gene transcriptional activi-
ties of MC3R, MC4R, and MC3/MC4R
chimeric receptors by melanocortin
agonist -MSH-ND in HEK 293T cells.
A, cAMP-mediated luciferase activity was
determined after stimulating MC3R and
MC4R and different MC3/MC4R chimeric
receptors in HEK 293T cells with -MSH-
ND. Data shown represent mean  S.E.
of at least five independent experiments.
B, maximal cAMP-mediated transcrip-
tional activity stimulated by -MSH-ND
at 106 M on MC3R, MC4R, and chimera
mutants in HEK 293T cells. Results are
mean  S.E. from four independent ex-
periments. *, p  0.05 and **, p  0.01,
significantly different from the corre-
sponding MC3R value.
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with alanine (T232A). In addition, isoleucine 235 and arginine
236 in MC4R were substituted with proline and glutamine,
respectively (I235P and R236Q), which are native amino acids
located at these positions in MC3R (Fig. 3). Other MC4R-
specific amino acids in the i3 loop, such as glycine 238, alanine
239, and asparagine 240 were also substituted with the amino
acids present at the same position in the i3 loop of MC3R,
respectively (G238H, A239S, and N240C). These mutant recep-
tors were examined in terms of their abilities to bind melano-
cortin receptor-specific ligands and for their abilities to trans-
duce signals at the cAMP level.
Table 5 summarizes ligand affinities for MC3R, MC4R, and
the 11 mutant MC4 receptors. All mutant receptors were found
to bind [125I]NDP-MSH, demonstrating that they were all ex-
pressed on the plasma membrane. In general, no significant
differences in the binding of [125I]NDP-MSH to the mutant
receptors were observed.
To assess whether the G-protein coupling efficiencies of the
mutant receptors differed from that of MC4R, we measured
their abilities to induce CRE-luciferase reporter gene activity.
Mutants R220A, T232V, and T232A showed enhanced reporter
gene activity, which was very near that of MC3R, whereas the
other mutant receptors had CRE-luciferase reporter gene ac-
tivities similar to that of MC4R (Fig. 4, A and B). The EC50
value of R220A was 12-fold lower than that of MC4R, and the
EC50 value of T232V and T232A was 6.5- and 5.9-fold, respec-
tively, lower than that of MC4R (Table VI). The mutant recep-
tors K224A (2.1-fold), R225A (3.5-fold), R236A (3.9-fold),
FIG. 4. Relative cAMP-mediated transcriptional activity of
MC3R, MC4R, and mutant receptors by NDP-MSH in HEK 293T
cells. A, cAMP-mediated transcriptional activity stimulated by NDP-
MSH on MC3R and MC4R, and on mutant receptors in HEK 293T cells.
Results are mean  S.E. from four independent experiments. B, max-
imal cAMP-mediated transcriptional activity stimulated by NDP-MSH
at 106 M on MC3R, MC4R, and mutant receptors in HEK 293T cells.
Results are mean  S.E. from four independent experiments. ***, p 
0.001, significantly different from the corresponding MC4R value.
TABLE IV
Summary of estimated EC50 values of the melanocortin agonist
-MSH-NDP for MC3R, MC4R and chimeric receptors
Kd and Bmax values were calculated at a 95% confidence interval
using GraphPad Prism software for binding assay using 125I-labeled
NDP-MSH upon MC3R and MC4R, and upon chimeric receptors ex-
pressed in HEX 293T cells. Values are the mean  S.E. from at least
three independent experiments.
Receptor EC50
nM
MC3R 1.309  0.367
MC4R 1.007  0.564
Chimera 1 3.303  0.782a
Chimera 2 11.372  6.128
Chimera 3 3.163  1.475
Chimera 4 2.988  0.725
a p  0.01 significantly different from corresponding MC3R value.
FIG. 3. Alignment of MC3Rs and MC4Rs focusing on the i3
loop. Black boxes indicate identities and gray boxes conservative sub-
stitutions. hMC4R, human MC4R; mMC4R, mouse MC4R; sMC4R, Sus
scrofa MC4R; bMC4R, Bos taurus MC4R; rMC3R, rat MC3R; hMC3R,
human MC3R. Mutations generated by site-directed mutagenesis in the
i3 loop domain of MC4R are indicated.
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R236Q (3.9-fold), and G238H (1.9-fold) showed slightly en-
hanced EC50 efficiencies, although their maximum CRE-lucif-
erase reporter gene activities were unchanged (Table VI). The
mutants I235P, A239S, and N240C showed no significant
changes in EC50 values or maximal reporter gene activity
(Fig. 4, Table VI). These data suggest that Arg220 and Thr232
are critical amino acid residues, and are implicated in the
specific G-protein coupling properties of MC4R.
Distinct Inositol Phosphate Signaling by MC3R and
MC4R—To determine the basis of the differential CRE-lucifer-
ase activity mediated by MC3R and MC4R more closely, we
assessed whether or not these receptors were coupled to other
signaling pathways, for example, the pathway involving phos-
pholipase C activation. An examination of the inositol phos-
phate (IP) levels in the cells transfected with either MC3R or
MC4R following exposure to the melanocortin peptides re-
vealed a significant stimulation of IP production by MC3R but
no detectable increase in IP production was observed by MC4R
stimulation, as presented in Fig. 5A. We also measured the IP
levels for the mutant MC4 receptors, however, none of these
mutants displayed melanocortin peptide-stimulated IP produc-
tion (Fig. 5B).
DISCUSSION
MC3R and MC4R are closely related melanocortin receptor
subtypes, which share 60% overall sequence homology (30, 31).
However, these two MCR subtypes are biologically distinguish-
able in a number of respects, for example, they show distinctive
agonist and antagonist binding affinities. Although both sub-
types couple to Gs and activate adenylyl cyclase on agonist
stimulation, the Gs coupling efficacy of MC4R is different from
that of MC3R (16). Moreover, MC3R and MC4R display dis-
tinctive tissue distribution patterns, suggesting that they have
different subtype-specific physiological roles. Gene “knock-out”
mouse models (13–15) have been established for MC3R and
MC4R resulting in different physiological outcomes. Recent
experiments in MC3R-null mice indicate that the inactivation
of MC3R results in an increased fat mass and a reduced body
mass despite being the fact that the animals were hypophagic
and maintained normal metabolic rates. This suggests the non-
redundancy of MC3R and MC4R in the regulation of energy
homeostasis (14, 15). A comparison of MC3R- and MC4R-null
mice phenotypes supports the idea that this melanocortin re-
ceptor subtype-specific mediated regulation of feeding behavior
appears to be controlled in a finely tuned manner. For example,
it has been suggested that in contrast to MC4R, which mainly
controls food intake, MC3R might regulate fat stores by some
specific metabolic pathway (31, 32).
TABLE V
125I-Labeled NDP-MSH binding to MC3R, MC4R,
and MC4R mutants
Kd and Bmax values were calculated with 95% confidence interval
using GraphPad Prism software for binding assay with the 125I-labeled
NDP-MSH on MC3R, MC4R, and MC4R mutants expressed in HEK
293T cells. Values are the mean  S.E. from at least three independent
experiments.
Bmax Kd
fmol/mg protein nM
MC3R 361.7  20.47 3.775  0.4906
MC4R 375.9  40.07 4.269  1.0090
R220A 325.9  25.23 3.893  0.6862
K224A 297.9  18.47 4.967  0.6529
R225A 323.8  26.67 4.066  0.7527
T232A 334.8  28.21 3.559  0.7007
T232V 304.8  34.29 3.514  0.9270
I235P 309.6  15.92 3.621  0.4330
R236A 296.3  38.75 4.081  1.1980
R236Q 282.0  41.17 4.529  1.4400
G238H 397.5  16.73 3.839  0.3505
A239S 339  28.43 4.858  1.303
N240C 346.5  32.56 3.005  0.5872
TABLE VI
Summary of estimated EC50 values of the melanocortin agonist
NDP-MSH for MC3R, MC4R and mutant MC4 receptors
EC50 values were determined for the cAMP-mediated luciferase re-
porter gene activity stimulated by NDP-MSH on MC3R and MC4R, and
MC4R mutants expressed in HEK293T cells. Data are mean  S.E.
from at least four independent experiments.
Mutant receptor EC50
nM
MC4R 4.86  1.18
MC3R 3.945  0.472
R220A 0.405  0.0939a
K224A 2.36  1.760
R225A 1.39  0.7258
T232A 0.870  0.201a
T232V 0.744  0.4138a
I235P 3.61  1.851
R236A 1.24  0.5365
R236Q 1.26  0.9031
G238H 2.442  1.205
A239S 4.783  0.6933
N240C 4.363  1.478
a p  0.05, significantly different from the EC50 values of MC4R.
FIG. 4—continued
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In our previous study, we compared the CRE-mediated re-
porter gene activity of MC3R versus MC4R and found that
MC4R showed 30–50% of the maximum activity induced by
MC3R. Moreover, this was not because of a difference in recep-
tor expression, as was shown by a receptor binding assay.
Differential CRE-mediated reporter gene transcription by
MC3R and MC4R suggests that MC3R and MC4R may have
different signaling efficiencies, in terms of G-protein coupling,
in addition to their specific ligand-receptor interactions, which
can specify a subtype-specific signaling pathway in vivo.
It has been shown that the third intracellular loop of several
G protein-coupled receptors is an important site for G-protein
coupling and specificity (10). Moreover, highly charged regions
of the third loop are strikingly conserved between the many
different seven-transmembrane receptors, and point mutations
or deletions affecting these regions disrupt normal signal
transduction by these receptors by altering their binding to
G-proteins (17–21). In the present study, by chimeric MC3R/
MC4R receptor study, we have demonstrated that the i3 loop in
MC3R and MC4R plays a pivotal role in G-protein coupling
specificity. Indeed, the i3 loop appears to be critical for full
activation of Gs protein for at least MC3R. Replacement of the
entire i3 loop of MC3R by MC4R resulted in a 60% decrease
in maximal reporter gene activity, which is similar to the
activity induced by MC4R. These findings indicate that the i3
loop is a critical structural determinant for the G-protein
coupling property in MC3R and MC4R.
Impaired Gs-mediated cAMP responsiveness was observed in
experiments with chimeric MC3R/MC4R receptor constructs,
especially in chimera 2, which had a reduced maximal response
to melanocortin. In addition its maximal cAMP response to
melanocortin was reduced, and its dose-response curve (EC50)
for melanocortin was shifted to the right. Maximal response
reflects the maximal number of melanocortin receptors that are
coupled to Gs and can be activated by melanocortin. The EC50
here represents the ability of the receptor to promote Gs cou-
pling to downstream effectors. The observation that chimera 2
exhibited a 60% decrease in maximal response, with a signifi-
cant change in EC50, suggests that the i3 loop determines the
G-protein coupling efficiency. Chimera 3, where the i3 loop and
the cytoplasmic COOH-terminal loop of MC3R were swapped
with the corresponding region of MC4R, also showed a signif-
icant decrease in maximal response but without a significant
change in EC50. It is possible that the interaction between the
i3 loop and the COOH-terminal is important for receptor-G
protein interactions, but that the i3 loop is the critical deter-
minant of G-protein coupling efficiency for MC3 and MC4 re-
ceptors. Indeed, chimera 4, in which only the cytoplasmic
COOH-terminal was swapped with that of MC4R did not sig-
nificantly affect CRE-luciferase reporter gene activity.
In many cases of G protein-coupled receptors, such as the
rhodopsin/-adrenergic receptor subfamily, the i3 loop has
been identified as an important structural domain, the resi-
dues of which couple to G-proteins and determine the specific-
ity of receptor-G protein interactions (33–35). Our present re-
sults show that the replacement of the i3 loop of MC3R, with
that of MC4R, suppresses its G-protein coupling efficiency, as
evidenced by the reduced CRE-luciferase activity.
The analysis of the amino acid composition of the third loop
of the known seven-transmembrane receptors shows the pres-
ence of highly charged residues in the loop. It is known that an
alteration of hydrophobic/hydrophilic amino acids can influ-
ence the secondary structure of proteins (36–38). More refined
analysis of the sequences of the i3 loop in different melanocor-
tin receptors has revealed that homologies are shared by
MC3R, MC4R, and MC5R. In the present study, the effects of
replacing charged amino acids, namely, Arg220, Lys224, and
Arg225, which are conserved in MC3R, MC4R, and MC5R, were
examined. A mutation introduced by replacing Arg220 with
alanine enhanced the EC50 13.9-fold versus native MC4R. Sim-
ilarly, replacing Thr232, which is specific to MC4R, with valine
or alanine also greatly enhanced CRE-luciferase activity by
7.6-fold (Table VI). These data indicate that these mutants
acquired an increased G-protein coupling efficiency. However,
when Ile235 or Arg236 were substituted with proline or gluta-
mine, the amino acid residues natively present in MC3R, re-
spectively, no significant changes in CRE-luciferase activity
versus MC4R were observed. The mutants I235P, A239S, and
N240C, where MC4R-specific amino acids were substituted by
the amino acids present at the same position in MC3R, did not
display significant changes in the CRE-luciferase activity by
the mutation. Therefore, the amino acid residues in the i3 loop
seem to be involved in the generation of structure or the mod-
ification of the environment of the protein, which confers G-
FIG. 5. Generation of IP by stimula-
tion with MC3R and MC4R in
HEK293T cells. A, time-dependent gen-
eration of [3H]IP in HEK 293T cells trans-
fected with MC3R and MC4R. The recep-
tors were stimulated by 108 M -MSH. B,
generation of [3H]IP by MC3R, MC4R,
and the different mutants receptors at 45
min after stimulation by the 108 M
-MSH in the HEK 293T cells.
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protein coupling selectivity. On the other hand, Thr232 might
represent a candidate site for phosphorylation, for example, the
phosphorylation involved in desensitization of the G protein-
coupled receptor.
To determine the basis of the differential CRE-luciferase
activity mediated by MC3R and MC4R more closely, we as-
sessed whether or not these receptors were coupled to other
signaling pathways, for example, the pathway involving phos-
pholipase C activation. It has been reported that MC3R is also
able to couple to Gq (39). An examination of the IP levels in the
cells transfected with either MC3R or MC4R following expo-
sure to the melanocortin peptides revealed a rapid stimulation
of IP production by MC3R but no detectable increase in IP
production was observed by MC4R stimulation, as presented in
Fig. 5. Therefore, it is suggested that this differential inositol
phospholipid signaling by MC3R and MC4R may also contrib-
ute to the differential CRE-luciferase activity mediated by
these two receptors. To a certain extent, because a CRE-re-
porter gene assay can effectively monitor both Gs and Gq acti-
vation by CREB-mediated gene expression (24, 25), this dis-
tinct inositol phospholipid signaling would be one of the
possible explanations for the differential CRE-reporter gene
activation profile between MC3R and MC4R. On the other
hand, the basal level of the reporter gene activity with MC4R in
the absence of stimulation with the melanocortin analogue is
actually higher than that of MC3R, suggesting that MC4R
could be constitutively activated.2 Our observation is consist-
ent with a recent report by Nijenhuis et al. (40), which also
suggests the relevance of the constitutive activity of MC4R.
This aspect would contribute to the distinct signaling pathway
mediated by MC3R and MC4R that was observed. Further-
more, this suggests that MC3R and MC4R signaling via the Gs
would be more complex and regulated in a fine way.
In conclusion, our study demonstrates that the activation of
different signaling pathways by the MC3R and MC4R recep-
tors have distinct conformational requirements. The third in-
tracellular loop of these receptors plays a crucial role in the
acquisition of these conformations, inasmuch as, depending on
the mutation in this region, it is possible to modify the selec-
tivity of the coupling and to selectively impair the ability of the
receptor to transduce a precise effect of melanocortin. Further-
more, our results suggest that MC3R and MC4R have distinct
signaling in either the cAMP- or the inositol phospholipid-
mediated pathway, and this appears to be regulated in a fine
tuned way, possibly to adapt the complex and tonic signaling
requirements for their physiological role in fuel homeostasis.
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